How has been the historical performance of Ganga Pharma.?

Answer:The historical performance of Ganga Pharma shows a consistent trend in its financial metrics over the years. Breakdown: Ganga Pharma's share capital remained stable at Rs 4.84 crore from March 2024 to March 2025, while total reserves increased slightly from Rs 1.59 crore in March 2024 to Rs 1.67 crore in March 2025. Shareholder's funds also saw a modest rise, reaching Rs 7.13 crore in March 2025, up from Rs 7.05 crore the previous year. Long-term borrowings decreased from Rs 0.39 crore in March 2024 to Rs 0.23 crore in March 2025, indicating a reduction in debt levels. Total liabilities increased to Rs 8.97 crore in March 2025 from Rs 8.65 crore in March 2024, while total assets also rose to Rs 8.97 crore in March 2025 from Rs 8.65 crore in March 2024. The book value per share adjusted slightly to Rs 13.46 in March 2025 from Rs 13.30 in March 2024. Cash flow from operating activities remained at zero across the years, with cash flow from investing activities showing a positive inflow of Rs 1 crore in March 2025, contrasting with no activity in the previous year. Overall, Ganga Pharma's financial position reflects stability with slight improvements in reserves and assets, while maintaining low debt levels.